Menu

Retiring Congressman to Lead AAAS

Rush Holt, a research physicist and former teacher who is leaving the US House of Representatives, will become executive publisher of the Science journals.

Nov 19, 2014
Tracy Vence

Rush HoltWIKIMEDIA, UNITED STATES CONGRESSThe American Association for the Advancement of Science (AAAS) has chosen Rush Holt (D-NJ) to succeed Alan Leshner as chief executive officer of the professional organization and executive publisher of Science and its related journals. Holt, who is retiring from the US House of Representatives at the end of his eighth term, is a research physicist and former faculty at Swarthmore College in Pennsylvania.

“Efforts to advance science, promote public engagement with science and technology, and ensure that accurate scientific information informs policy decisions—core AAAS activities—have also been central to Holt’s long record of public service,” the association said in a statement announcing Holt’s hire.

Holt, who has represented New Jersey in Congress since 1999, earned a PhD in physics from New York University in 1981. He was awarded an AAAS Science & Technology Policy Fellowship in 1982.

“I look forward to supporting the association’s mission to advance science, engineering, and innovation throughout the world, for the benefit of all people,” he said in the AAAS statement.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!